Fundraising Fox
/Companies
Sign in

Prota Therapeutics

Melbourne, AU · Founded 2016 · 2 known investors

Find your way into Prota Therapeutics

Sign up to see every warm intro you have to Prota Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Prota Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Prota Therapeutics is a late clinical-stage biotech company developing allergen oral immunotherapies to treat food allergies, with a lead phase-3-ready product (PRT120) targeting peanut allergy. Its technology originated from research led by Professor Mimi Tang at the Murdoch Children's Research Institute in Melbourne, Australia.

BiotechDigital Health

Founders & leadership

Prota Therapeutics was founded in 2016 by Mimi Tang.

MTMimi Tang
Mimi TangFounding CEO, Scientific FounderA clinical immunologist and allergist, she has led allergy translation and allergy immunology research groups at the Murdoch Childrens Research Institute since 2003, and served as a consultant immunologist allergist at The Royal Children's Hospital from 1998 to 2025, including as director of its Department of Immunology and later its Department of Allergy & Immunology. She chairs the advisory board of the ASEAN-Australia Centre and has been a board director of Prota Therapeutics since 2024.
DM
DR MARK HASLETONActing CEO

Investors · 2

Also in the syndicate · 1

SPRIM Global Investments (SGI)lead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Prota Therapeutics Strengthens Board with Appointment of Global Biotech Expert Patrick Machadoglobenewswire.com · Jul 2024

Frequently asked questions

What does Prota Therapeutics do?
Prota Therapeutics is a late clinical-stage biotech company developing allergen oral immunotherapies to treat food allergies, with a lead phase-3-ready product (PRT120) targeting peanut allergy. Its technology originated from research led by Professor Mimi Tang at the Murdoch Children's Research Institute in Melbourne, Australia.
Who founded Prota Therapeutics?
Prota Therapeutics was founded by Mimi Tang in 2016.
Who are Prota Therapeutics's investors?
Prota Therapeutics's investors include OneVentures.
Where is Prota Therapeutics headquartered?
Prota Therapeutics is headquartered in Melbourne, AU.